Cargando…
Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478626/ https://www.ncbi.nlm.nih.gov/pubmed/34400588 http://dx.doi.org/10.5045/br.2021.2020245 |
_version_ | 1784576103461945344 |
---|---|
author | Anguiano-Álvarez, Víctor Manuel Maza-Larrea, José Antonio Rosado-Hernández, Francisco Javier Rojas-Velasco, Gustavo Izaguirre-Ávila, Raúl |
author_facet | Anguiano-Álvarez, Víctor Manuel Maza-Larrea, José Antonio Rosado-Hernández, Francisco Javier Rojas-Velasco, Gustavo Izaguirre-Ávila, Raúl |
author_sort | Anguiano-Álvarez, Víctor Manuel |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8478626 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
record_format | MEDLINE/PubMed |
spelling | pubmed-84786262021-10-09 Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient Anguiano-Álvarez, Víctor Manuel Maza-Larrea, José Antonio Rosado-Hernández, Francisco Javier Rojas-Velasco, Gustavo Izaguirre-Ávila, Raúl Blood Res Letters to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2021-09-30 2021-09-30 /pmc/articles/PMC8478626/ /pubmed/34400588 http://dx.doi.org/10.5045/br.2021.2020245 Text en © 2021 Korean Society of Hematology https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letters to the Editor Anguiano-Álvarez, Víctor Manuel Maza-Larrea, José Antonio Rosado-Hernández, Francisco Javier Rojas-Velasco, Gustavo Izaguirre-Ávila, Raúl Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient |
title | Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient |
title_full | Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient |
title_fullStr | Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient |
title_full_unstemmed | Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient |
title_short | Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient |
title_sort | ruxolitinib-induced extreme thrombocytosis in a covid-19 patient |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478626/ https://www.ncbi.nlm.nih.gov/pubmed/34400588 http://dx.doi.org/10.5045/br.2021.2020245 |
work_keys_str_mv | AT anguianoalvarezvictormanuel ruxolitinibinducedextremethrombocytosisinacovid19patient AT mazalarreajoseantonio ruxolitinibinducedextremethrombocytosisinacovid19patient AT rosadohernandezfranciscojavier ruxolitinibinducedextremethrombocytosisinacovid19patient AT rojasvelascogustavo ruxolitinibinducedextremethrombocytosisinacovid19patient AT izaguirreavilaraul ruxolitinibinducedextremethrombocytosisinacovid19patient |